Exousia Bio (LMMY) Cost of Revenue (2024 - 2026)
Exousia Bio (LMMY) posted Cost of Revenue of $62108.0 for Q4 2025, up 756.54% sequentially from $7251.0 in Q2 2025.
Powered by 
Analysis
Exousia Bio (LMMY) Cost of Revenue (2024 - 2026) Analysis & Trends
Exousia Bio (LMMY) has 2 years of Cost of Revenue data on file, last reported at $62108.0 in Q4 2025.
- Quarterly Cost of Revenue changed N/A year-over-year to $62108.0 in Q4 2025, while the trailing twelve-month figure through Feb 2026 was $69359.0 (up 447.56% YoY) and the FY2025 annual result came in at $7251.0, down 24.99% from the prior year.
- Cost of Revenue rose to $62108.0 in Q4 2025 per LMMY's latest filing, from $7251.0 in the prior quarter.
- The five-year high for Cost of Revenue was $62108.0 in Q4 2025, with the low at $3000.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | New Oriental Education & Technology | 94.93 Bn | 92.19 Bn | 812.22 Mn | 717.31 Mn |
| 2 | Laureate Education | 5.10 Bn | 4.93 Bn | 237.67 Mn | 378.20 Mn |
| 3 | Graham Holdings | 4.82 Bn | 3.58 Bn | 777.03 Mn | 525.48 Mn |
| 4 | Covista | 4.53 Bn | 4.12 Bn | 284.63 Mn | 216.75 Mn |
| 5 | Grand Canyon Education | 4.00 Bn | 3.73 Bn | 204.08 Mn | 59.96 Mn |
| 6 | Stride | 3.71 Bn | 2.75 Bn | 217.28 Mn | 418.78 Mn |
| 7 | McGraw Hill | 2.56 Bn | 2.37 Bn | 439.20 Mn | 110.70 Mn |
| 8 | Perdoceo Education | 2.10 Bn | 795.81 Mn | 162.46 Mn | 50.89 Mn |
| 9 | TAL Education | 1.94 Bn | -740.46 Mn | 227.32 Mn | 202.24 Mn |
| 10 | Exousia Bio | 368,824.87 | 368,824.87 | -62,108.00 | 62,108.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Feb 28, 2026 | 62,108.00 |
| Nov 30, 2025 | 62,108.00 |
| May 31, 2025 | 7,251.00 |
| Aug 31, 2024 | 3,000.00 |
| May 31, 2024 | 9,667.00 |